Altrova Health Inc.

As of March 31, 2026, ALTROVA HEALTH INC carries a market capitalization of 5.64M, placing it among publicly traded companies globally. Its enterprise value stands at 5.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, ALTROVA HEALTH INC has 201.08M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 51.38, and the price-to-book ratio stands at 3.33.

These figures are as of March 31, 2026. The EV/Sales ratio of 52.61 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 5.35M versus a market cap of 5.64M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, ALTROVA HEALTH INC maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, ALTROVA HEALTH INC posted a negative return on equity (ROE) of -130.37, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -98.76, reflecting losses generated across the asset base.

As of the close on October 22, 2026, ALTROVA HEALTH INC's stock has gained approximately 59.78% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.04.

Over the twelve months ended March 31, 2026, ALTROVA HEALTH INC generated 101,774.67 in revenue and converted that into -3.37M in net income, yielding earnings per share of -0.02. EBITDA reached -1.43M, while operating income came in at -1.45M.

These figures are as of March 31, 2026. Total book value stands at 1.69M, with working capital of -636,701.47 providing operational flexibility.

ALTROVA HEALTH INC produced -554,792.62 in operating cash flow over the twelve months ended March 31, 2026. After subtracting -257,088.62 in capital expenditures, free cash flow totaled -811,881.24 - equivalent to 0.00 per share.

These figures cover the twelve months ended March 31, 2026. The operating margin of -1,424.34 and net profit margin of -3,311.71 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -15.53: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 46.44, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to ALTROVA HEALTH INC shareholders.

ALTROVA HEALTH INC's most recent stock split took place on October 3, 2023 with a 4:1 split ratio.

As of March 31, 2026, ALTROVA HEALTH INC has an Altman Z-Score of -47.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.